Levine L
J Am Optom Assoc. 1985 Jul;56(7):542-8.
To minimize the risk of adverse side effects from mydriatics during binocular indirect ophthalmoscopy, a procedure was developed which intentionally starts with a dose significantly less than an ED99. Using a clinically effective diameter of greater than 7 mm as a criterion, I found that 1 drop of 0.5% tropicamide (T) constituted an ED74 (N = 46). When 1 drop of 2.5% phenylephrine (P) was added, this increased to an ED93 (N = 27). If present results can be generalized, then 1 drop of T, supplemented at 30 minutes with 1 drop of P, if necessary, should produce satisfactory dilatation in approximately 90% of the subjects.
为了将双目间接检眼镜检查期间使用散瞳剂产生副作用的风险降至最低,我们开发了一种程序,该程序有意从显著低于ED99的剂量开始。以大于7mm的临床有效直径为标准,我发现1滴0.5%托吡卡胺(T)构成ED74(N = 46)。当添加1滴2.5%去氧肾上腺素(P)时,这增加到ED93(N = 27)。如果目前的结果可以推广,那么1滴T,如果必要的话,在30分钟后补充1滴P,应该能在大约90%的受试者中产生令人满意的散瞳效果。